Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pfizer's Next Multibillion-Dollar COVID Vaccine Move


Pfizer (NYSE: PFE) made one of the smartest decisions in the company's long history earlier this year. It chose to partner with German biotech BioNTech (NASDAQ: BNTX) on the development and commercialization of its COVID-19 vaccine. And the rest, as they say, is history.

The companies' BNT162b2 COVID-19 vaccine became the first to win U.S., U.K., and Canadian emergency use authorizations (EUA). They lined up deals to supply hundreds of millions of doses through 2021.

Pretty much everything has gone right so far, but that might not always be the case. Billions of dollars could hinge on Pfizer's next major COVID vaccine move.

Continue reading


Source Fool.com

Like: 0
PFE
Share

Comments